Bank Of New York Mellon Corp Plus Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2020 May 06, 2020	BUY	$1.05 - $2.85 $2,332 - $6,329	2,221 Added 7.72%	30,984 $58,000
Q4 2019 Feb 14, 2020	BUY	$1.99 - $3.23 $57,238 - $92,904	28,763 New	28,763 $69,000

Ticker PSTV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,601,400
Market Cap $36.6M
Description
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, lep...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.